Hui Yang

Hui Yang began their work experience as an Associate Scientist at Amgen in June 2017. They worked in this role until July 2020. From August 2020 to July 2021, they served as a Postdoctoral Research Scientist at Universitätsklinikum Schleswig-Holstein. Following this, Hui Yang joined The Janssen Pharmaceutical Companies of Johnson & Johnson as a Senior Scientist in August 2021 and worked until January 2022. Currently, they are working at I-Mab Biopharma as a Principal Scientist starting from January 2022.

Hui YANG obtained a Bachelor's degree in Biotechnology Pharmaceutical from Shenyang Pharmaceutical University from 2010 to 2011. They then went on to pursue a Doctor of Philosophy (PhD) in Pharmacology at the University of Chinese Academy of Sciences, completing their degree from 2011 to 2017. Prior to this, from 2007 to 2010, Hui YANG was a joint training student in Biotechnology Pharmaceutical at Jilin University.